Robot-assisted retroperitoneal lymph node dissection: Feasibility and outcome in postchemotherapy residual mass in testicular cancer
Conclusion: RA-RPLND is safe and feasible for postchemotherapy residual mass with accepted compilation rate, but larger studies are required to establish its diagnostic and therapeutic utility along with safety of the procedure.
Source: Indian Journal of Urology - Category: Urology & Nephrology Authors: Amitabh Singh Smaranjit Chatterjee Prashant Bansal Abhishek Bansal Sudhir Rawal Source Type: research
More News: Cancer | Cancer & Oncology | Diets | Germ Cell Tumors | India Health | Nutrition | Study | Teratoma | Testicular Cancer | Urology & Nephrology